Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI

E-ISSN： 1741-203x|20|1|40-46

ISSN： 1041-6102

Source： International Psychogeriatrics, Vol.20, Iss.1, 2008-02, pp. : 40-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short-term practice effects in amnestic mild cognitive impairment: implications for diagnosis and treatment

International Psychogeriatrics, Vol. 20, Iss. 5, 2008-10 ,pp. : 986-999

Cambridge University Press

Access to resources Recommend Favorite

Could cholinesterase inhibitors be harmful over the long term?

International Psychogeriatrics, Vol. 24, Iss. 2, 2011-12 ,pp. : 171-174

Cambridge University Press

Access to resources Recommend Favorite

The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer's dementia and vascular dementia

International Psychogeriatrics, Vol. 24, Iss. 6, 2012-06 ,pp. : 959-966

Cambridge University Press

Access to resources Recommend Favorite

The evidence for the efficacy of cholinesterase inhibitors in the treatment of Alzheimer's disease is convincing

International Psychogeriatrics, Vol. 20, Iss. 2, 2008-04 ,pp. : 279-286

Cambridge University Press

Access to resources Recommend Favorite

FOR DEBATE: IS THE EVIDENCE FOR THE EFFICACY OF CHOLINESTERASE INHIBITORS IN THE SYMPTOMATIC TREATMENT OF ALZHEIMER'S DISEASE CONVINCING OR NOT?

International Psychogeriatrics, Vol. 20, Iss. 2, 2008-04 ,pp. : 259-260

Cambridge University Press

Access to resources Recommend Favorite